Postmenopausal Women with Breast, Endometrial, and Ovarian Cancers Have an Increased Risk for Cardiovascular Conditions prior to Active Endocrine Therapy

Table 3

The serum lipid control among cancer patients.

(%)	Total	Breast cancer	Endometrial cancer	Ovarian cancer	value
TC (mmol/L)					<0.001
Appropriate level,	5782 (53.9)	4134 (51.8)	775 (56.4)	873 (63.8)
Borderline high,	3171 (29.5)	2419 (30.3)	408 (29.7)	344 (25.1)
High,	1778 (16.6)	1434 (18.0)	192 (14.0)	152 (11.1)
LDL (mmol/L)					<0.001
Ideal level,	3702 (34.5)	2696 (33.8)	465 (33.8)	541 (39.5)
Appropriate level,	4277 (39.9)	3153 (39.5)	559 (40/7)	565 (41.3)
Borderline high,	1928 (18.0)	1496 (18.7)	243 (17.7)	189 (13.8)
High LDL, ≥4.1 L	824 (7.7)	642 (8.0)	108 (7.9)	74 (5.4)
HDL (mmol/L)					<0.001
Low HDL, <1.0	4730 (44.1)	3249 (40.7)	706 (51.3)	775 (56.6)
Non-HDL (mmol/L)					<0.001
Ideal level, non-	3340 (32.1)	2475 (31.0)	432 (31.4)	533 (38.9)
Appropriate level, non-	3269 (30.5)	2418 (30.3)	426 (31.0)	425 (31.0)
Borderline high,	2568 (23.9)	1958 (24.5)	344 (25.0)	266 (19.4)
High, non-	1454 (13.5)	1136 (14.2)	173 (12.6)	145 (10.6)
TG (mmol/L)					<0.001
Appropriate level,	7518 (70.1)	5520 (69.1)	921 (67.0)	1077 (78.7)
Borderline high,	1721 (16.0)	1319 (16.5)	228 (16.6)	174 (12.7)
High,	1492 (13.9)	1148 (14.4)	226 (16.4)	118 (8.6)

HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; non-HLD-C: non-high-density lipoprotein cholesterol; TC: total cholesterol; TG: triglycerides.